You just read:

The Minneapolis Medical Research Foundation Selects Goodwin Biotechnology to Help Develop and Manufacture Two Vaccines to Treat Opioid Addiction

News provided by

Goodwin Biotechnology, Inc.

Mar 20, 2017, 09:00 ET